Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0U3PC
|
|||
Former ID |
DNC012282
|
|||
Drug Name |
1-Benzo[b]thiophen-2-yl-cycloheptylamine
|
|||
Synonyms |
CHEMBL18811; NCI60_038329; 1-Benzo[b]thiophen-2-yl-cycloheptylamine; AC1L9GG6; CTK7D5124; ZINC1657601; BDBM50040194; 1-(benzothiophen-2-yl)cycloheptan-1-amine; 1-(1-benzothiophen-2-yl)cycloheptan-1-amine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H19NS
|
|||
Canonical SMILES |
C1CCCC(CC1)(C2=CC3=CC=CC=C3S2)N
|
|||
InChI |
1S/C15H19NS/c16-15(9-5-1-2-6-10-15)14-11-12-7-3-4-8-13(12)17-14/h3-4,7-8,11H,1-2,5-6,9-10,16H2
|
|||
InChIKey |
BCBMINBNEZGMJJ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dopamine transporter (DAT) | Target Info | Inhibitor | [1] |
KEGG Pathway | Dopaminergic synapse | |||
Parkinson's disease | ||||
Cocaine addiction | ||||
Amphetamine addiction | ||||
Alcoholism | ||||
Panther Pathway | Adrenaline and noradrenaline biosynthesis | |||
Parkinson disease | ||||
Dopamine receptor mediated signaling pathway | ||||
Pathway Interaction Database | Alpha-synuclein signaling | |||
Reactome | Na+/Cl- dependent neurotransmitter transporters | |||
WikiPathways | Monoamine Transport | |||
NRF2 pathway | ||||
Dopaminergic Neurogenesis | ||||
Parkinsons Disease Pathway | ||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | ||||
Neurotransmitter Clearance In The Synaptic Cleft |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and biological evaluation of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine homologues at dopamine-uptake and phencyclidine- and sigma-bin... J Med Chem. 1993 Apr 30;36(9):1188-93. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.